IBDverse multitissue atlasing cohort
Download from source ↗Dataset overview
Cell-type-resolved genetic variation shapes inflammatory bowel disease risk.
Abstract
Most genetic variants associated with complex diseases lie in non-coding regions<sup>1</sup>, complicating efforts to identify effector genes and relevant cell types. Here we map cis-expression quantitative trait loci (eQTLs) across 2.2 million single cells using intestinal biopsies and blood from 421 individuals, including 125 with inflammatory bowel disease (IBD). Cell-type-level eQTLs were more distal to transcription start sites, enriched in enhancers, less likely to regulate the nearest gene, and more than 3.5-fold more likely to colocalize with IBD loci detected in genome-wide association studies (GWASs) than eQTLs detected at tissue-level resolution. We nominate effector genes at more than half of known IBD loci, including MAML2, PSEN2 and ZMIZ1 in myeloid cells, implicating reduced Notch signalling in intestinal immune dysfunction. We also identify Wnt-regulated genes, including MYC, in epithelial stem and progenitor cells, suggesting that impaired renewal contributes to barrier breakdown. Our results provide a mechanistic map that links genetic risk to specific genes and cell types in IBD, and a generalized framework for interpretation of GWAS loci using single-cell eQTL mapping of disease-relevant tissues in complex diseases.
doi:10.1038/s41586-026-10627-z ↗ PMID 42236949 ↗ PMC13441992 ↗
Study facts
- Organism
- Homo sapiens
- Platform
- 10x Genomics Chromium
- Age group
- adult
- Disease groups
- —
- Anatomical sites
- blood, ileum, rectum
Data availability
- Processed matrix
- Analysis code
File types
H5AD
Files and samples
Strengths & limitations for reuse
Strengths
- Raw reads are advertised
- Processed matrices are advertised
- Cell metadata are advertised
- Analysis code is available
- Participant counts are documented
Limitations
- Not documented: raw counts are advertised
Extraction evidence & provenance
Each extracted field is shown with the source excerpt and location used to resolve it.
Assay
| Field | Value | Evidence |
|---|---|---|
assay.assay_type |
10x 3' v3 from source |
assay=10x 3' v3 Section |
assay.library_chemistry |
10x 3' v3 from source |
"assay": [{"label": "10x 3' v3", "ontology_term_id": "EFO:0009922"}] Section |
assay.platform |
10x Genomics Chromium |
scRNA-seq was performed using 3′ 10X Genomics Chromium kits (v3.0 and v3.1) Section |
assay.reference_genome |
GRCh38 with Ensembl v93 transcript definitions |
CellRanger (v7.2.0) was used to align reads to the GRCh38 human genome reference with Ensembl v93 transcript definitions Section |
assay.sequencing_type |
scrna_seq from source |
sequencing_type=scrna_seq Section |
Cohort
| Field | Value | Evidence |
|---|---|---|
cohort.age_group |
adult inferred |
"development_stage": [{"label": "60-79 year-old stage"}, {"label": "adult stage"}, {"label": "middle aged stage"}, {"label": "prime adult stage"}, {"label": "young adult stage"}] Section |
cohort.crohns_disease_participants |
125 |
296 individuals without IBD and 125 individuals with CD were recruited Section |
cohort.disease_activity_metadata_available |
True |
Ileal biopsies from patients with CD included both inflamed and uninflamed tissue. Section |
cohort.non_ibd_controls |
296 |
296 individuals without IBD and 125 individuals with CD were recruited Section |
cohort.total_participants |
421 |
296 individuals without IBD and 125 individuals with CD were recruited Section |
Data_Assets
| Field | Value | Evidence |
|---|---|---|
data_assets.analysis_code |
True |
Code used to perform all analyses is available at https://github.com/andersonlab/IBDVerse-sc-eQTL-code Section |
data_assets.cell_metadata |
True from source |
CELLxGENE dataset exposes cell metadata Section |
data_assets.open_access |
True from source |
public CELLxGENE dataset Section |
data_assets.participant_metadata |
True from source |
"donor_id": ["IBDverse-1-FB0463BF47ACA3", "IBDverse-1-C3245D4242DB7A", "IBDverse-1-2A825F3279742E"] Section |
data_assets.processed_matrix |
True from source |
CELLxGENE dataset exposes H5AD Section |
data_assets.raw_reads |
True from source |
"link_name": "EGAD00001015692", "link_type": "RAW_DATA" Section |
Processing
| Field | Value | Evidence |
|---|---|---|
processing.ambient_rna_correction_reported |
True |
corrected for ambient RNA using CellBender v2.1 Section |
processing.batch_correction_reported |
True |
Data were integrated using the scVI v0.16.3 function scvi.model.SCVI Section |
processing.cell_type_annotation_method |
CellTypist model trained on the atlasing dataset with expert manual annotation |
a CellTypist v1.6.2 model was trained on the atlasing dataset Section |
processing.normalization_method |
Library-size normalization to 10,000 counts per cell followed by log1p transformation |
normalizing to library sizes of 10,000 total counts using the function sc.pp.normalise_per_cell and log transformation using sc.pp.log1p Section |
processing.quality_control_reported |
True |
A lineage-sensitive, relative quality control strategy was applied Section |
Specimens
| Field | Value | Evidence |
|---|---|---|
specimens.anatomical_sites |
['blood', 'ileum', 'rectum'] from source |
tissues=blood, ileum, rectum Section |
specimens.inflamed_status_available |
True |
Ileal biopsies from patients with CD included both inflamed and uninflamed tissue. Section |
specimens.number_of_cells |
1852681 from source |
cell_count=1852681 Section |
specimens.number_of_samples |
732 inferred |
275 healthy rectal biopsies, 119 CD terminal ileal biopsies, 243 healthy terminal ileal biopsies and 95 blood samples Section |
specimens.specimen_type |
mixed inferred |
During routine endoscopy, gastrointestinal biopsies were collected from the rectum and terminal ileum, and blood samples were drawn after the procedure. Section |